Alembic Limited (BOM:506235)

India · Delayed Price · Currency is INR

87.16

-1.91 (-2.14%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Active Pharmaceutical Ingredient (API)	322.15M	317.42M	264.88M	322.66M	284.95M
Active Pharmaceutical Ingredient (API) Growth	1.49%	19.84%	-17.91%	13.24%	-44.23%
Real Estate	1.90B	1.26B	1.01B	459.51M	450.21M
Real Estate Growth	50.84%	24.80%	119.26%	2.07%	97.15%
Total	2.22B	1.57B	1.27B	782.18M	735.16M
Total Growth	40.89%	23.77%	62.68%	6.39%	-0.55%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	74.38M	71.19M	84.98M	119.69M	75.06M
India Growth	4.48%	-16.22%	-29.00%	59.47%	-78.87%
Exports	25.03M	37.02M	16.80M	17.37M	12.03M
Exports Growth	-32.38%	120.41%	-3.33%	44.43%	-28.51%
Unallocated	2.12B	1.47B	1.17B	645.11M	648.08M
Unallocated Growth	44.51%	25.28%	81.47%	-0.46%	76.45%
Total	2.22B	1.57B	1.27B	782.18M	735.16M
Total Growth	40.89%	23.77%	62.68%	6.40%	-0.55%

Source: S&P Global Market Intelligence.